ZVRA compared with SCYX: revenue, margins and what each company keeps, and the suppliers and customers both name

ZVRAZevra Therapeutics, Inc.

Mkt capRevenueRevenue

SCYXScynexis Inc

Mkt capRevenueRevenue

Compare

ZVRAZevra Therapeutics, Inc.

SCYXScynexis Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SCYX: latest quarter not drawable.Method ›

Price

rebased to 0%

ZVRA, solidSCYX, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ZVRA 6

—Aquestive Therapeuticsunlistedsupplier

—Orphazyme A/Sunlistedsupplier

—Reliefunlistedsupplier

—Xomaunlistedsupplier

2 more · ZVRA chain ›

Shared 0

No shared counterparties.

Only SCYX 4

—Merckunlistedsupplier

—GlaxoSmithKline Intellectual Property (No. 3) Limited (GSK)unlistedcustomer

—Hansohunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—R-Pharmunlistedcustomer

ZVRAZevra Therapeutics, Inc.

10.28▼−0.73%· post 10.28

Mkt cap$610.5MRevenue$40MQ2 FY26Revenue$106MFY25

SCYXScynexis Inc

3.78▼−2.20%· post 3.71

ClosedOct 30 '26

Mkt cap$37.5MRevenue$235,000Q2 FY26Revenue$21MFY25

Compare

ClosedOct 30 '26

ZVRAZevra Therapeutics, Inc.

SCYXScynexis Inc

10.28▼−0.73%post 10.28

Price

3.78▼−2.20%post 3.71

$610.5M

Mkt cap

$37.5M

Q2 FY26$40M

Revenue

$235,000Q2 FY26

FY25$106M

Revenue

$21MFY25

ZVRA10.28▼−0.73%vsSCYX3.78▼−2.20%ClosedOct 30 '26